神外前沿讯,贝伐珠单抗在脑胶质瘤治疗中是一个老生常谈的话题。2025年1月2日, Mayo Clinic团队在journal of Neuro-Oncology杂志(影响因子3.2,JCR分区Q2)上报道了脑胶质瘤贝伐珠单抗领域的研究进展。 在这项单中心回顾性队列研究中,研究者发现,与低剂量贝伐珠单抗(< 5 毫克/千克/周)治疗相比,脑胶质瘤患者接受常...
The role of research has been integrally tied to the primary goal of patient care as well as education, consistent with Mayo Clinic's philosophy that medicine must be developed as a cooperative science between the clinician, the specialist, and the laboratory, all for the good of the patient....
“Off-the-shelf ginseng is sometimes processed using ethanol, which can give it estrogen-like properties that may be harmful to breast cancer patients,” says researcher Debra Barton, Ph.D., of the Mayo Clinic Cancer Center. At four weeks, the pure ginseng provided only a slight improvement ...
Pharmacy Times: What makes the Mayo Clinic oncology pharmacy unique?Soefje: People always ask, what's the secret sauce of Mayo Clinic? The secret sauce of Mayo Clinic is teamwork. When we convince the practice that they need the pharmacist in their team, then they become par...
globulin ATRAAll-trans retinoic acid BPH Benign prostatic hyperplasia Ca Calcium CABG Coronary artery elevated risk of breast cancer; these mutations can be detected in the patient's normal cellsdoi:10.1016/S0025-6196(12)65055-1H. Clark HoaglandELSEVIERMayo Clinic Proceedings...
Mayo Clinic Laboratories takes the lead in designing and optimizing oncology testing based on specific cancer types. Our comprehensive test menu includes evaluations that aid in providing both diagnostic and prognostic information and treatment selection guidance across the full spectrum of malignancies. By...
Jodi Taraba, PharmD, MS, BCOP, a breast cancer clinical pharmacist at Mayo Clinic, offers insights into the pivotal role of pharmacists in driving clinical trial research and enhancing patient care and treatment outcomes at Mayo Clinic. Her comments on the benefits of integrating onc...
Mayo Clinic Radiation Oncology: Current Practice and Future Direction is intended to provide balanced and multidisciplinary discussion of contemporary cancer treatment. Time: 18:00 - 12:00
MADISON, Wis.,Feb. 20, 2024/PRNewswire/ -- Elephas Biosciences Corporation (Elephas), a biotechnology company, today announced that it will collaborate on the development of an oncology imaging diagnostics platform to predict response to immunotherapy with Ma...
Elephas Biosciences Corporation (Elephas), a biotechnology company, today announced that it will collaborate on the development of an oncology imaging diagnostics platform to predict response to immunotherapy with Mayo Clinic Comprehensive Cancer Center. [20-February-2024...